4.6 Article

Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin

Related references

Note: Only part of the references are listed.
Article Rheumatology

Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study

Ming Fu et al.

Summary: The incidence and disability-adjusted life years (DALYs) of hip osteoarthritis have been increasing globally, particularly in developed regions. The trends in incidence and DALYs vary across nations and regions, indicating the need to increase awareness regarding risk factors and consequences of hip osteoarthritis.

ARTHRITIS RESEARCH & THERAPY (2022)

Article Dentistry, Oral Surgery & Medicine

Tibolone, alendronate, and simvastatin enhance implant osseointegration in a preclinical in vivo model

Dragos Apostu et al.

CLINICAL ORAL IMPLANTS RESEARCH (2020)

Article Medicine, Research & Experimental

Current methods of preventing aseptic loosening and improving osseointegration of titanium implants in cementless total hip arthroplasty: a review

Dragos Apostu et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)

Article Orthopedics

Partial versus early full weight bearing after uncemented total hip arthroplasty: a meta-analysis

Peng Tian et al.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2017)

Review Pharmacology & Pharmacy

Systemic drugs that influence titanium implant osseointegration

Dragos Apostu et al.

DRUG METABOLISM REVIEWS (2017)

Article Orthopedics

Partial weightbearing is not necessary after cementless total hip arthroplasty

Max Markmiller et al.

INTERNATIONAL ORTHOPAEDICS (2011)

Article Orthopedics

Immediate Weight Bearing After Cementless Total Hip Replacement

Charles J. Taunt et al.

ORTHOPEDICS (2009)

Article Endocrinology & Metabolism

Alendronate inhibits periprosthetic bone loss around uncemented femoral components

Takashi Nishioka et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2007)